Tag

Guidelines

All articles tagged with #guidelines

Study prompts rethinking lifelong beta-blocker therapy after heart attack
health12 days ago

Study prompts rethinking lifelong beta-blocker therapy after heart attack

A South Korean NEJM study found that among stable, low-risk heart-attack survivors, stopping beta-blockers after one year was as safe as continuing them for years: 58 events (7.2%) vs 74 (9%), deaths 2.4% vs 3.4%, recurrent heart attack 2.3% vs 2.6%, and heart-failure hospitalizations about 2% in both groups, with modest increases in BP/HR but SBP kept under 130. The results—alongside evolving guidelines—suggest lifelong beta-blockers may not be necessary for all, supporting shared decision-making and potential cost savings, though not all patients are candidates and further data are needed.

Endometriosis: New guidelines push symptom-based, earlier diagnosis Across Specialties
health15 days ago

Endometriosis: New guidelines push symptom-based, earlier diagnosis Across Specialties

ACOG’s updated endometriosis guidance allows clinicians to diagnose and start treatment based on symptoms and exam (no mandatory surgical confirmation), with transvaginal ultrasound as first-line imaging and MRI for later characterization. The recommendations apply to adolescents as well as adults and urge cross-specialty recognition (pediatrics, gastroenterology, urology, internal medicine) to shorten the historically long diagnostic timeline. The shift aims to move care earlier, reduce disease progression and infertility impact, and address systemic barriers highlighted by patient stories like Leah Chapman, who faced years of pain, multiple IVF cycles, and advocacy efforts to improve access and awareness.

Cholesterol guidelines tighten focus on early prevention and personalized risk
cardiovascular-health23 days ago

Cholesterol guidelines tighten focus on early prevention and personalized risk

The American Heart Association and American College of Cardiology have updated dyslipidemia guidelines, prioritizing earlier lifestyle-based prevention, a modern cardiovascular risk calculator (PREVENT) to guide treatment, and additional tests (CAC, Lp(a), ApoB) to refine risk and LDL-C lowering decisions; the updates also address hypertriglyceridemia therapies and recommend cholesterol screening for kids aged 9–11 to identify familial hypercholesterolemia early and reduce lifetime cardiovascular risk.

Men's pre-conception health linked to healthier pregnancies, experts urge inclusion in guidelines
health24 days ago

Men's pre-conception health linked to healthier pregnancies, experts urge inclusion in guidelines

A Lancet review argues that men’s health and partner support before and during pregnancy influence outcomes for mothers and children, and calls for including paternal health in pre-conception guidelines. It notes lifestyle and clinical factors such as smoking, obesity, high blood pressure, alcohol use, and age can affect sperm quality and fertility, while partner involvement improves pregnancy experience and outcomes. A separate Lancet study across countries found consistent priorities for pregnancy planning—physical and mental health, stability, and partner support—highlighting the need for policy changes to monitor reproductive-age health and to support diverse gender identities.

Guidelines push cholesterol screening and treatment to age 30 and up
health24 days ago

Guidelines push cholesterol screening and treatment to age 30 and up

Major medical groups—including the American Heart Association and the American College of Cardiology—issued updated guidelines recommending cholesterol screening and lipid-lowering treatment begin as young as age 30 if lifestyle changes aren’t enough. The guidelines call for measuring lipoprotein(a) once in adulthood, set LDL targets of <100 mg/dL for lower/intermediate risk and <70 mg/dL for high risk, and emphasize statins as the foundation with non-statin therapies considered when needed to reduce long-term heart attack and stroke risk.

2026 Lipid Guidelines Use PREVENT Scores to Tailor Therapy
health27 days ago

2026 Lipid Guidelines Use PREVENT Scores to Tailor Therapy

The 2026 American dyslipidemia guideline endorses PREVENT-ASCVD risk equations to guide primary prevention therapy and suggests considering lipid-lowering treatment for adults at intermediate risk based on a 10-year PREVENT-ASCVD risk, with additional considerations for borderline risk and for patients with moderate subclinical atherosclerosis, aiming to lower LDL cholesterol.

Cholesterol guidelines urge earlier screening and expanded biomarker testing
health28 days ago

Cholesterol guidelines urge earlier screening and expanded biomarker testing

New cholesterol guidelines urge starting screening in your 30s and using lifetime risk (via the PREVENT calculator) alongside 10-year risk to guide treatment. Targets are LDL <100 mg/dL for most, <70 mg/dL for high-risk individuals, and <55 mg/dL for those with existing heart disease, with statins considered earlier; the guidance also recommends apoB testing after LDL goals and universal lipoprotein(a) testing once in adulthood, plus calcium scoring for those at borderline/intermediate risk, all aiming to reduce lifetime LDL exposure and prevent cardiovascular events.

2026 Acute PE Guideline Introduces Five-Category Risk System to Guide Management
health1 month ago

2026 Acute PE Guideline Introduces Five-Category Risk System to Guide Management

The 2026 AHA/ACC guideline for acute PE introduces a five-category Acute PE Clinical Categories system (A–E) to sharpen risk stratification and guide therapy; patients with higher risk (categories C–E) or cardiopulmonary failure should be hospitalized, and for those eligible for oral anticoagulation, direct oral anticoagulants are preferred over vitamin K antagonists to prevent recurrent VTE and reduce major bleeding.

Most statin side effects lack evidence, major meta-analysis finds
health2 months ago

Most statin side effects lack evidence, major meta-analysis finds

A Lancet meta-analysis of 19 large randomized trials (over 122,000 participants) finds that most reported statin side effects are not supported by reliable evidence, with real adverse effects being rare (about 1% muscle symptoms; rare rhabdomyolysis; small increases in liver tests and glucose for those near diabetes thresholds). The benefits remain substantial: roughly 25% lower risk of heart attack or stroke and meaningful LDL reductions, with inexpensive generic options (~$40/year). Updated PREVENT-based risk estimates could expand who should start statins, underscoring that fears of side effects should not unduly deter appropriate preventive therapy.

Daily aspirin myth debunked as new science flags risks for healthy adults
health2 months ago

Daily aspirin myth debunked as new science flags risks for healthy adults

Longstanding NHS guidance that daily low-dose aspirin protects the heart is being re-evaluated. In people with no prior cardiovascular disease, the benefits are limited and risks—such as stomach bleeding and brain haemorrhages—are significant; this has led to updated NHS guidance since 2021 and a 2023 recommendation to avoid routinely offering aspirin to prevent a first heart attack. The NHS still recommends daily aspirin for those who have had a heart attack or stroke, but many healthy patients remain unaware of risks. Doctors urge discussions with GPs about individual risk and highlight alternatives (blood pressure control, statins, exercise) as safer, more effective preventive measures. Some patients report severe side effects, underscoring why broad daily aspirin use should be avoided unless clinically indicated.

Protein isn’t a limitless fuel: science suggests you probably don’t need ultra-high amounts
health2 months ago

Protein isn’t a limitless fuel: science suggests you probably don’t need ultra-high amounts

A Nature science brief argues that while protein is essential, most people don’t benefit from the ultra-high intakes promoted by influencers; the body can only use protein up to a point, with diminishing returns beyond standard dietary recommendations, making highly fortified foods and excessive protein diets unnecessary for the average adult.

England to publish first official screen-time guidance for under-fives
education2 months ago

England to publish first official screen-time guidance for under-fives

England will publish its first official screen-time guidance for children under five in April, with a national working group set to consult parents and practitioners on how much screen use is appropriate and to offer non-screen activity alternatives. Government research shows about 98% of children under two use screens daily, and higher screen time (around five hours) is linked to significantly fewer words spoken compared with those who watch less. The guidance, led by Dame Rachel de Souza and Professor Russell Viner, aims to help families manage screens as part of a broader push on digital literacy and online safety, while highlighting income-based disparities in how children are read to.

WHO releases guidelines endorsing GLP-1 drugs for obesity treatment
health4 months ago

WHO releases guidelines endorsing GLP-1 drugs for obesity treatment

The World Health Organization has issued its first guideline on using GLP-1 medicines to treat obesity, emphasizing that these therapies can support long-term management of obesity alongside lifestyle changes, but should be part of a comprehensive approach. The guideline highlights the importance of equitable access, health system readiness, and multisectoral strategies to address the global obesity crisis, which affects over 1 billion people and causes millions of deaths annually.